Publication
·
Reaid Hasan, Zhen Zhao, Yuanke Li, Yanli Liu, Yuanyuan Zhang, Kun
Cheng. (2025) Small
Extracellular Vesicles (sEVs) in Pancreatic Cancer
Progression and Diagnosis. Journal of Controlled Release 380:269-282
· Zhen Zhao, John Fetse, Umar-Farouk Mamani, Yuhan Guo, Yuanke Li,
Pratikkumar Patel, Yanli Liu, Chien-Yu Lin, Yongren Li, Bahaa
Mustafa, Kun Cheng (2025) Development
of a Peptide-Based Tumor-Activated Checkpoint Inhibitor for Cancer
Immunotherapy. Acta Biomaterialia 193:484-497
·
Umar-Farouk Mamani, Mohammed Nurudeen Ibrahim,
Yanli Liu, John Fetse, Chien-Yu Lin, Sashi Kandel, Maryam Nakhjiri, Sushil
Koirala, Yuhan Guo, Mohammad Alahmari, Kun Cheng (2024). Exploring
Multivalency in the Development of Anti-PD-L1 Peptides for Cancer
Immunotherapy. Pharmaceutical Research 41(12):2275-2288 (selected as the journal cover
page)
·
Sheri Shaji, Pratikkumar Patel, Umar-Farouk Mamani, Yuhan Guo, Sushil
Koirala, Chien-Yu Lin, Mohammad Alahmari, Evanthia Omoscharka, Kun Cheng (2024) Delivery of a STING agonist
using lipid nanoparticles inhibits pancreatic cancer growth. International
Journal of Nanomedicine 19:8769-8778
·
Sun 18(2):258-284
·
Pengfei
Yu, Hainan Zhu, Carol Christine Bosholm, Daniella
Beiner1, Zhongping Duan, Avinash Shetty, Steve Mou, Philip Adam Kramer, Luis F. Barroso, Hongbing Liu, Kun Cheng, Michael
Ihnat, Matthew A. Gorris, Joseph A. Aloi, Jobira A. Woldemichael, Anthony
Bleyer, and Yuanyuan Zhang. (2023) Precision Nephrotoxicity Testing
Using 3D in vitro Models. Cell & Bioscience. 13:231
·
Jing Zhou, Nan Lyu, Qiongling Wang, Ming Yang, Eric
T. Kimchi, Kun Cheng, Trupti Joshi, Adama R Tukuli, Kevin F Staveley-O’Carroll, Guangfu Li. (2023)
A novel role of TGFBI in macrophage polarizaqtion and
macrophage-induced pancreatic cancer growth and therapeutic resistance. Cancer Lett. Oct
19:216457
·
Bahaa Mustafa, John Fetse, Sashi Kandel,
Chien-Yu Lin, Pratik Adhikary, Umar-Farouk Mamani, Yanli Liu, Mohammed Nurudeen Ibrahim, Mohammed Alahmari, Kun Cheng. (2023) Discovery
of Anti-CD47 Peptides as New Innate Immune Checkpoint
Inhibitors. Advanced Therapeutics, 2300114
·
Chien-Yu
Lin, Evanthia Omoscharka, Yanli Liu, Kun Cheng. (2023)
Establishment of a Rat Model of Alcoholic Liver Fibrosis with Simulated Human
Drinking Patterns and Low-Dose Chemical Stimulation. Biomolecules 13(9):
1293
·
Carol
Christine Bosholm, Hainan Zhu, Pengfei Yu, Kun Cheng, Sean Murphy,
Patrick Michael McNutt, Yuanyuan Zhang. (2023) Therapeutic Benefits of Stem
Cells and Exosomes for Sulphur Mustard-Induced Tissue Damage. International
Journal of Molecular Sciences. 24(12), 9947
·
John Fetse, Sashil Kandel,
Umar-Farouk Mamani, Kun Cheng (2023) Recent
Advances in the Development of Therapeutic Peptides. Trends in Pharmacological Sciences. 44(7):425-441
·
Chien-Yu
Lin, Umar-Farouk Mamani, Yuhan Guo, Yanli Liu, Kun Cheng (2023)
Peptide-Based siRNA Nanocomplexes Targeting Hepatic Stellate Cells. Biomolecules 13(3): 448
·
Pratikkumar Patel, John Fetse, Chien-Yu Lin,
Yuhan Guo, Md Reaid Hasan, Maryam Nakhjiri, Zhen Zhao, Akshay Jain, and Kun
Cheng. (2022) Development of Amino Acid-Modified Biodegradable
Lipid Nanoparticles for siRNA Delivery. Acta Biomaterialia 154:374-384
·
John
Fetse, Zhen Zhao, Hao Liu, Umar-Farouk Mamani, Bahaa Mustafa, Pratik Adhikary,
Mohammed Ibrahim, Yanli Liu, Pratikkumar Patel, Maryam Nakhjiri, Mohammed
Alahmari, Guangfu Li, Kun Cheng. (2022) Discovery
of Cyclic Peptide Inhibitors Targeting PD-L1 for Cancer Immunotherapy. Journal of
Medicinal Chemistry 65(18):12002-12013
·
Hao Liu, Yanli Liu, Zhen Zhao, Yuanke Li, Bahaa
Mustafa, Zhijin Chen, Ashutosh Barve, Akshay Jain, Xiaolan Yao, Guangfu Li, Kun Cheng.
(2022) Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer
Immunotherapy. Frontiers in Immunology 13: Article 838966
·
Bahaa
Jawad, Puja Adhikari, Kun Cheng, Rudolf Podgornik, Wai-Yim Ching. (2022)
Computational
design of miniproteins as SARS-CoV-2 therapeutic
inhibitors. International Journal of Molecular Sciences 23(2): 838
·
Pratik Adhikary, Sashi Kandel, Bahaa Mustafa, Umar-Farouk Mamani,
Siyuan Hao, Qianming Qiu, John Fetse, Yanli
Liu, Mohammed Ibrahim Nurudeen, Yongren Li, Chien-Yu Lin, Evanthia
Omoscharka, Kun Cheng. (2021) Discovery
of Small Anti-ACE2 Peptides to Inhibit SARS-CoV-2 Infectivity. Advanced
Therapeutics https://doi.org/10.1002/adtp.202100087
·
Sashi Kandel, Pratik Adhikary, Guangfu Li, Kun Cheng. (2021) The
TIM3/Gal9 Signaling Pathway: An Emerging Target for Cancer Immunotherapy. Cancer
Letters 510:67-78
·
Chien-Yu
Lin, Pratik Adhikary, Kun Cheng. (2021) Cellular Protein Markers, Therapeutics, and
Drug Delivery Strategies in the Treatment of Diabetes-Associated Liver Fibrosis. Advanced Drug Delivery Reviews 174:127-139
·
Pratikkumar Patel, Mohammed Ibrahim Nurudeen, Kun Cheng.
(2021) The
Importance of Apparent pKa in the Development of
Nanoparticles Encapsulating siRNA and mRNA. Trends in Pharmacological
Sciences 42(6):1-13
·
Xinjian Liu, Hao Yuan, Jing Zhou, Qiongling
Wang, Xiaoqiang Qi, Catharine Bernal, Diego Avella,
Jussuf T. Kaifi, Eric T. Kimchi1, Kun Cheng, Yi Miao, Kuirong Jiang*, Guangfu Li*. (2021) LMO7
as an unrecognized factor promoting pancreatic cancer progression and
metastasis. Frontiers in Cell and
Developmental Biology. 08 March, Volume 9, Article 647387
·
Yuanke Li, Zhen Zhao, Chien-Yu Lin,
Yanli Liu, Kevin F. Staveley-OCarroll, Guangfu Li, Kun Cheng. (2021) Silencing
PCBP2 Normalizes Desmoplastic Stroma and Improves the Antitumor Activity of
Chemotherapy in Pancreatic Cancer. Theranostics. 11(5):2182-2200
·
Xiaoqiang Qi, Ming
Yang, Lixin Ma, Madeline Sauer, Diego Avella,
Jussuf T. Kaifi, Jeffrey Bryan, Kun Cheng, Kevin F.
Staveley-O’Carroll, Eric T. Kimchi, Guangfu Li. (2020)
Synergizing sunitinib and radiofrequency ablation to treat
hepatocellular cancer by triggering the antitumor immune response, Journal for ImmunoTherapy of Cancer. Oct;8(2):e001038
· Ashutosh Barve, Akshay Jain,
Hao Liu, Zhen Zhao, Kun Cheng. (2020) Enzyme-Responsive
Polymeric Micelles of Cabazitaxel for Prostate Cancer Targeted Therapy Acta
Biomaterialia. 113:501-511
· Zhen Zhao, Yuanke Li, Hao
Liu, Akshay Jain, Pratikkumar Patel, Kun Cheng (2020) Co-Delivery of
IKBKE siRNA and Cabazitaxel by Hybrid Nanocomplex Inhibits the Invasiveness and
Growth of Triple-Negative Breast Cancer. Science Advances. 6 (29), eabb0616
· Yuanke Li, Zhen Zhao, Hao
Liu, John Peter Fetse, Akshay Jain, Chien-Yu Lin, Kun Cheng. (2019) Development
of a Tumor-Responsive Nanopolyplex Targeting Pancreatic Cancer Cells and Stroma.
ACS Applied Materials & Interfaces. 11(49):45390-45403
· Zhen Zhao, Chien-Yu Lin, Kun Cheng (2019) siRNA- and miRNA-Based Therapeutics for Liver Fibrosis. Translational Research. 214:17-29
·
Akshay
Jain, Ashutosh Barve, Zhen Zhao, John Peter Fetse, Hao Liu, Kun Cheng.
(2019) Targeted
Delivery of an siRNA-PNA Hybrid Nanocomplex Reverses Carbon
Tetrachloride-Induced Liver. Advanced
Therapeutics 2(8):1900046
·
Hao Liu,
Zhen Zhao, Li Zhang, Yuanke Li, Akshay Jain, Ashutosh Barve, Wei Jin, Yanli
Liu, John Fetse, Kun Cheng (2019) Discovery
of Low-Molecular Weight Anti-PD-L1 Peptides for Cancer Immunotherapy. Journal for ImmunoTherapy
of Cancer 7(1):270
·
Zhen
Zhao, Yuanke Li, Ravi Shukla, Hao Liu, Akshay Jain, Ashutosh Barve,
Kun Cheng (2019) Development
of a Biocompatible Copolymer
Nanocomplex to Deliver VEGF siRNA for Triple Negative Breast Cancer. Theranostics.
9(15):4508-4524
·
Zhijin Chen, Akshay Jain, Hao Liu, Zhen
Zhao, Kun Cheng (2019) Targeted
Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis.
Journal of
Pharmacology and Experimental Therapeutics. 370(3):695-702
·
Wei
Jin, Akshay Jain, Hao Liu, Zhen Zhao, Kun Cheng (2018) Noncovalent
Attachment of Chemical Moieties to siRNA Using Peptide Nucleic Acid As a
Complementary Linker. ACS Applied Bio Materials. 1(3):
643-651
·
Zhen Zhao,
Yuanke Li, Akshay Jain, Zhijin Chen, Hao Liu, Wei Jin, Kun Cheng (2018) Development
of a Peptide-Modified siRNA Nanocomplex for Hepatic Stellate cells. Nanomedicine: Nanotechnology, Biology, and
Medicine. 14(1):51-61
·
Chang Liu,
Li Zhang, Hao Liu, Kun Cheng (2017) Delivery
Strategies of the CRISPR-Cas9 Gene-Editing System for Therapeutic Applications. Journal of Controlled Release. 266:17-26 (Most
downloaded articles in the last 90 days, ranked 2nd on 12/29/2017)
·
Zhijin
Chen, Hao Liu, Akshay Jain, Li Zhang, Chang Liu, Kun Cheng (2017) Discovery
of Aptamer Ligands for Hepatic Stellate Cells Using SELEX. Theranostics 7(12): 2982-2995
·
Hao Liu, Zhijin
Chen, Wei Jin, Ashutosh Barve, Yu-Jui Yvonne Wan, Kun Cheng (2017) Silencing
αCP2 Reverses the Alcohol- and Cytokine-Induced Fibrogenesis in Primary Hepatic
Stellate Cells. Liver Research 1:70-79
·
Akshay Jain, Ashutosh Barve, Zhen
Zhao, Wei Jin, Kun Cheng (2017) Comparison
of avidin, neutravidin, and streptavidin as nanocarrier for efficient siRNA
delivery. Molecular Pharmaceutics
14(5):1517-1527 (Winner of the AAPS Physical Pharmacy and Biopharmaceutics
Section Best Manuscript Contest for the year 2017)
·
Akshay Jain, Kun Cheng
(2017) The
Principles and Applications
of Avidin-Based Nanoparticles in Drug Delivery and Diagnosis, Journal of Controlled Release. 245:27-40
·
Wei Jin, Bin Qin, Zhijin Chen, Hao Liu,
Ashutosh Barve, Kun Cheng. (2016) Discovery
of PSMA-Specific Peptide for Targeted Drug Delivery to Prostate Cancer.
International Journal of Pharmaceutics. 513:138-147 (Highlighted by Uro Today on 09/08/16)
·
Ashutosh Barve,
Akshay Jain, Hao Liu, Wei Jin, Kun Cheng (2016) An
Enzyme-Responsive Conjugate Improves the Delivery of a PI3K Inhibitor to
Prostate Cancer. Nanomedicine:
Nanotechnology, Biology, and Medicine. 12(8):2373-2381
·
Ravi S. Shukla, Akshay Jain, Zhen
Zhao, Kun Cheng. (2016) Intracellular
Trafficking and Exocytosis of a Multi-Component siRNA Nanocomplex. Nanomedicine:
Nanotechnology, Biology, and Medicine. 12(5):1323-34
·
Wei Jin, Ashutosh Barve, Kun
Cheng. (2016) PSMA-Specific
Ligands in Prostate Cancer Diagnosis and Therapy. European Medical Journal Urology. April 26th (selected as the ‘Editor’s Pick’ by the Editor-in-Chief. A small opening
paragraph within the journal introduces this paper and highlighting its quality
and relevance.) 4(1): 62-69
·
Zhijin Chen, Wei Jin, Hao Liu,
Zhen Zhao, Kun Cheng. (2015) Discovery
of Peptide Ligands for Hepatic Stellate Cells Using Phage Display,
Molecular Pharmaceutics 12(6):2180-8
·
Ti Zhang, Huizhong Cui, Chia-Yi Fang, Kun Cheng,
Xinmai Yang, Huan-Cheng Chang and M. Laird
Forrest. (2015) Targeted nanodiamonds as
phenotype-specific photoacoustic contrast agents for breast cancer, Nanomedicine (Lond). 10(4):573-87
·
Ravi Shukla, Bin Qin, Kun Cheng. (2014) Peptides
used in the delivery of small non-coding RNA, Molecular
Pharmaceutics, 11:3395-408 (Journal’s Top 20 Most Read Articles over the last 1 months,
ranked No. 3 on 09/26/14)
·
Ashutosh Barve, Wei Jin, Kun Cheng.
(2014) Prostate
Cancer Relevant Antigens and Enzymes for Targeted Drug Delivery,
Journal of Controlled Release, 187:118-32
·
Wanyi Tai, Zhijin Chen, Ashutosh Barve,
Zhonghua Peng, Kun Cheng. (2014) A
novel rapamycin-polymer conjugate based on a new poly(ethylene glycol)
multiblock copolymer. Pharmaceutical
Research 31(3):706-19
·
Ravi S. Shukla, Kun Cheng (2014) “Site
Specific Ocular Nucleic Acid Delivery” in Avi Domb (Ed.) “Advances in Delivery Science and Technology-
Focal Drug Therapy” CRC Press
·
Ravi Shukla, Wanyi Tai, Rubi Mahato, Wei Jin, Kun
Cheng. (2013) Development
of a streptavidin-based nanocomplex for siRNA delivery, Molecular Pharmaceutics 10(12):4534-45
·
Bin Qin; Zhijin Chen; Wei Jin; Kun Cheng.
(2013) Development
of cholesteryl peptide micelles for siRNA delivery, Journal of Controlled Release,
172(1):159-168
·
Wanyi Tai, Zhijin
Chen, Kun Cheng. (2013) Expression
profile and functional activity of peptide transporters in prostate cancer
cells. Molecular
Pharmaceutics 10(2):477-87 (Featured by Global Medical Discovery on 07/17/2013)
·
Bin Qin, Wei Jin, Kun
Cheng (2013) “Bioconjugation for site-specific delivery of siRNA” in Kun
Cheng and Ram I. Mahato (Eds) “Advanced Delivery
and Therapeutic Applications of RNAi” Wiley-Blackwell,
John Wiley & Sons, Inc.
·
Ravi S. Shukla, Zhijin Chen, Kun Cheng
(2013) “Strategies of targeted drug delivery” in Ashim K. Mitra, Chi H. Lee,
and Kun Cheng (Eds) “Advanced Drug Delivery” Wiley-Blackwell, John Wiley & Sons, Inc.
·
Shaoying
Wang, Bin Qin, Kun Cheng (2013) “Delivery of nucleic acids” in Ashim K.
Mitra, Chi H. Lee, and Kun Cheng (Eds) “Advanced Drug Delivery” Wiley-Blackwell, John Wiley & Sons, Inc.
·
Wanyi Tai, Kun Cheng (2013) “Advanced
drug delivery in cancer therapy” in Ashim K. Mitra, Chi H. Lee, and Kun
Cheng (Eds) “Advanced Drug Delivery” Wiley-Blackwell,
John Wiley & Sons, Inc.
·
Bin Qin, Ravi S. Shukla, Kun Cheng
(2012) “Delivery of nucleic acids for ocular gene modulation” in Mitra AK edits
“Advances in Ocular Drug Delivery”, Research Singpost/Transworld
Research Network
·
Kun Cheng,
Ram I. Mahato. (2011) Biological and therapeutic applications of small RNAs. Pharmaceutical Research 28(12):2961-5
·
Ravi S. Shukla, Bin Qin, Kun Cheng.
(2011) PCBP2 siRNA reverses the alcohol-induced pro-fibrogenic
effect in hepatic stellate cells. Pharmaceutical
Research 28(12):3058-68
·
Bin Qin, Wanyi Tai Ravi S. Shukla, Kun Cheng.
(2011) Identification of a LNCaP-specific binding peptide using phage display.
Pharmaceutical Research 28(10):2422-34
·
Wanyi Tai, Ravi S. Shukla, Bin Qin, Benyi Li, Kun
Cheng. (2011) Development of a peptide-drug conjugate for prostate cancer
therapy. Molecular Pharmaceutics Jun
6;8(3):901-12 (Highlighted by SciBX: Science-Business eXchange, May 5 2011, Volume 4/Number 18; Featured by
Global Medical Discovery on 09/19/2011; Molecular Pharmaceutics_Top
20 Most Downloaded Articles over the last 1 month, ranked No. 14 on 06/09/2011;
reported as “Reports Summarize Prostate Cancer Research from University of
Missouri”
by NewsRx on 07/27/2011)
·
Rubi Mahato, Wanyi Tai, Kun Cheng.
(2011) Prodrugs for improving tumor targetability and efficiency. Advanced Drug Delivery Review 2011 Jul
18;63(8):659-70
·
Rubi Mahato, Bin Qin, Kun Cheng. (2011)
Blocking IKK-α Expression Inhibits Prostate Cancer Invasiveness. Pharmaceutical Research 28(6):1357-69
·
Bin Qin, Kun Cheng. (2010) Silencing of
the IKKɛ gene by siRNA inhibits invasiveness and
growth of breast cancer cells. Breast
Cancer Research 12(5):R74. (highlighted in the Target Intelligence
Service, a database used by pharmaceutical companies worldwide to identify
ground breaking research of relevance to their own work on potential drug
targets; Breast Cancer Research_Top
20 Most Accessed Articles for last 30 days, ranked No. 6 on 10/20/10)
·
Wanyi Tai, Rubi Mahato, Kun Cheng.
(2010) The role of HER2 in cancer therapy and targeted drug delivery. Journal of Controlled Release 146(3):264-75
(Journal of Controlled Release_Most
Downloaded Articles, ranked No. 4 on 10/11/10)
·
Wanyi Tai, Bin Qin, Kun Cheng. (2010)
Inhibition of breast cancer cell growth and invasiveness by dual silencing of
HER-2 and VEGF. Molecular Pharmaceutics 7(2):
543-556 (reported as “New breast cancer study findings
reported from University of Missouri” by NewsRx on
05/31/2010)
·
Kun Cheng,
Ram I. Mahato (2009) siRNA delivery and targeting. Molecular Pharmaceutics 6(3):649-650, Editorial (Journal’s Top 20
Most Downloaded Articles over the last 12 months, ranked No. 14 on 10/11/10)
·
Kun Cheng,
NingNing Yang, Ram I. Mahato (2009) TGF-β1 Gene Silencing for Treating Liver
Fibrosis. Molecular Pharmaceutics
6(3):772-779
·
Kun Cheng,
Bin Qin. (2009) RNA Interference for Cancer Therapy in Lu Y, Mahato RI. edits
“Pharmaceutical Perspectives of Cancer Therapeutics”, AAPS-Springer publishing
program
·
Lin Zhu, Zhaoyang Ye,
Kun Cheng, Duane D. Miller, Ram I. Mahato (2008), Site-specific Delivery
of Oligonucleotides to Hepatocytes after Systemic Administration. Bioconjugate Chemistry 19:290-298
·
Kun
Cheng, Ram I. Mahato (2007) Gene Modulation for
Treating Liver Fibrosis (review) Critical
Reviews in Therapeutic Drug Carrier Systems, 24:93-146
·
Xiangxu
Jia, Kun Cheng, Ram I.
Mahato (2007) Co-expression of Vascular Endothelial Growth Factor and
Interleukin-1 Receptor Antagonist for Improved Human Islet Survival and
Function. Molecular Pharmaceutics, 4:199-207
·
Kun
Cheng, Zhaoyang Ye, Ramareddy V. Guntaka and Ram I. Mahato (2006) Enhanced Hepatic Uptake and
Bioactivity of Type α1(I) Collagen Gene Promoter Specific Triplex Forming
Oligonucleotides after Conjugation with Cholesterol. Journal of Pharmacology
and Experimental Therapeutics, 317:797-805
·
Zhaoyang
Ye, Kun Cheng, Ramareddy V. Guntaka and Ram I. Mahato (2006)
Biodistribution and Hepatic Uptake of M6P-BSA-TFO in Normal and Fibrotic Rats. Bioconjugate
Chemistry, 17:823-830
·
Kun Cheng,
Ram I. Mahato. (2006) Biopharmaceutical Challenges in Pulmonary Delivery of
Proteins and Peptides in Meibohm B. edits
“Pharmacokinetics and Pharmacodynamics of Biotech Drugs”, Wiley-VCH, Weinheim,
Germany
·
Kun
Cheng, Zhaoyang Ye, Ramareddy V. Guntaka and Ram I. Mahato (2005) Biodistribution and Hepatic Uptake of Triplex
Forming Oligonucleotides in Normal and Fibrotic Rats. Molecular
Pharmaceutics, 2:206 -217
·
Zhaoyang
Ye, Kun Cheng, Ramareddy V. Guntaka and Ram I. Mahato (2005) Targeted
Delivery of a Triplex Forming Oligonucleotide to Hepatic Stellate Cells. Biochemistry,
44:4466 -4476
·
Ram I. Mahato, Kun Cheng, Ramareddy V. Guntaka.
(2005) Modulation of Gene Expression by
Antisense, Antigene and RNAi. Expert Opinion on
Drug Delivery, 2:3-28
·
Cheng
K,
Fraga D, Zhang C, Kotb M, Gaber AO, Guntaka RV, and Mahato RI (2004)
Adenovirus-Based Vascular Endothelial Growth Factor Gene Delivery to Human
Pancreatic Islets. Gene Therapy, 11:1105-16
·
Narang AS, Cheng K, Henry J, Zhang C, Sabek O, Fraga D, Kotb M, Gaber AO
and Mahato RI (2004) Vascular endothelial growth factor gene delivery for
revascularization in transplanted human islets. Pharm Res. 21:15-25
·
Cheng
K and Lim LY (2004) Insulin-loaded calcium
pectinate nanoparticles: Effect of pectin molecular weight and formulation pH. Drug Dev Ind Pharm. 30:359-367
·
Zhang JH, Zhu JB, Chen XJ, Zhao R, Gang YY, Wu
ZH, Cheng K and Xu XY
(2001) Pharmacokinetics and bioavailability of sustained release and
conventional formulation of acyclovir. Eur
J Drug Metab Pharmacokinet.
26:145-8
·
Cheng
K, Zhu J, Song X, Sun L and Zhang JH (1999)
Studies of hydroxypropyl methylcellulose donut-shaped tablets. Drug Dev Ind
Pharm. 25:1067-71
·
Cheng
K, Zhu JB and Yang SC (1999) Technology of
preparation of nimodipine solid lipid nanoparticles. Chinese Journal of
Pharmaceuticals (Zhongguo Yiyao
Gongye Zazhi).
30:441-444
·
Cheng
K and Zhu JB (1999) Comparison and Evaluation of
Some Methods for Population Pharmacokinetic Analyses. China Pharmacist. 2:45-48
Patent
·
Peptide Ligands
for Hepatic Stellate Cells (Inventors: Kun Cheng and Zhijin Chen), US 15/288,837
·
Prostate-Specific Membrane Antigen (PSMA) Targeting Peptides
(Inventors: Kun
Cheng and Wei Jin), US
16/535,720
· Polypeptides And Compositions Comprising The Same (Inventors: Kun Cheng, Hao Liu, Fetse John, Umar-Farouk Mamani), US 17/507,301
Book
1. Kun
Cheng
and Ram I. Mahato (Eds) “Advanced Delivery and
Therapeutic Applications of RNAi” Wiley-Blackwell,
John Wiley & Sons, Inc. (2013)
2.
Ashim
Mitra, Chi H. Lee, and Kun Cheng (Eds) “Advanced Drug Delivery” Wiley-Blackwell, John Wiley & Sons, Inc.
(2013)
Journal Theme Issue
1. Kun Cheng
and Ram I. Mahato (Eds)
Special Issue entitled “siRNA Delivery” (2009) Molecular Pharmaceutics. 6(3):649-1040
2. Kun Cheng
and Ram I. Mahato (Eds) Theme
Issue entitled “Biological and therapeutic applications of small RNAs” (2011) Pharmaceutical
Research 28(12): 2961-3104
